Table 3.
Summary of 23 reported cases of EB virus-positive plasma cell tumors
| Patients | n = 22 |
| Age (y)/gender | n = 17 |
| 1.2-78 (46) | |
| Unknown: 5 | |
| n = 16 | |
| M:F = 13:3 | |
| Unknown: 6 | |
| Underlying disease | n = 11 |
| None: 4 | |
| Chronic renal failure: 2 | |
| Hepatic failure: 1 | |
| HIV: 3 | |
| Hodgkin’s lymphoma: 1 | |
| RA: 1 | |
| Unknown: 11 | |
| Treatment | n = 12 |
| None: 6 | |
| Organ transplantation: 4 | |
| CsA: 4 | |
| AZA: 3 | |
| PSL: 5 | |
| ALG: 1 | |
| SASP: 1 | |
| MTX: 1 | |
| TAC: 1 | |
| Unknown: 10 | |
| Clinical findings | n = 20 |
| Extramedullary mass: 12 | |
| Bone lesion: 5 | |
| Ileum ulcer: 1 | |
| Shortness of breath: 1 | |
| Abdominal pain: 1 | |
| Ascites: 1 | |
| Dementia: 1 | |
| Fever: 1 | |
| Clouding of consciousness: 1 | |
| Lethargy: 1 | |
| Polyuria: 1 | |
| Polydysplasia: 1 | |
| Slurred speech: 1 | |
| Purulent rhinorrhea: 1 | |
| Dyspnea: 1 | |
| Otitis media: 1 | |
| None: 1 | |
| Unknown: 2 | |
| Type of myeloma | n = 17 |
| IgA: 1 | |
| IgG: 7 | |
| IgM: 1 | |
| κ: 9 | |
| λ: 3 | |
| Plasmacytoma: 11 | |
| Plasmablastic: 4 | |
| Non-plasmablastic: 1 | |
| Time from onset of underlying disease to that of myeloma (yr) | n = 7 |
| 0.9-12 (median: 4) | |
| No underlying disease: 4 | |
| Unknown: 11 | |
| Treatment of myeloma | n = 12 |
| Corticosteroids (incl. PSL): 2 | |
| DEXA: 2 | |
| RT: 7 | |
| Ex: 3 | |
| CT: 4 | |
| Thal: 1 | |
| BD: 1 | |
| Auto-PBSCT: 1 | |
| Immunosuppressants discont’d or dose reduced: 4 | |
| Unknown: 10 | |
| Therapeutic response | n = 11 |
| Remission (improved): 10 | |
| Not improved: 1 | |
| Unknown: 11 | |
| Outcome | n = 11 |
| Surviving: 4 | |
| DOMM: 3 | |
| Died of infection: 2 | |
| Died, cause unknown: 2 | |
| Unknown: 11 |